CaaMTech
PrivateLast Round
Series A
Sep 8, 2021
Total Funding Raised
$23.35M
Company Overview
CaaMTech operates in Healthcare & Life Sciences and is based in Issaquah, Washington. Its latest recorded funding round was a Series A round in September 2021.
CaaMTech is a pharmaceutical drug discovery company that engineers and optimizes novel psychedelic-inspired small-molecule therapeutics to treat mental health conditions.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Mental Health
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CaaMTech Comparables
Compare CaaMTech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Psilera | 87% | |
| Gilgamesh Pharmaceuticals | 86% | |
| Lophora | 83% |
For institutional investors. Book with your work email.
CaaMTech Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CaaMTech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Noetic Fund | Series A |
| Mont Alto Capital | Series A |
| Kortschak Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors increased 159% MoM, reaching 4.1K.
- Sep 8, 2021
$22M round led by Noetic Fund.
For institutional investors. Book with your work email.
CaaMTech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CaaMTech's valuation, stock price, and market status.
Is CaaMTech a public or private company?
CaaMTech is a private company.
What is the current stock price of CaaMTech?
CaaMTech is a private company, so its shares have no public market price. Caplight tracks CaaMTech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CaaMTech worth (valuation)?
Valuation information for CaaMTech is not publicly available.
Can I buy CaaMTech stock?
CaaMTech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CaaMTech's last funding round?
CaaMTech's most recent funding round was Series A on September 8, 2021.
Who are the main investors in CaaMTech?
Key investors in CaaMTech include Noetic Fund.
Will CaaMTech IPO soon?
No public IPO plans have been announced for CaaMTech.
How can I track CaaMTech secondary market activity?
Caplight tracks bids, offers, and trades in CaaMTech's shares on secondary markets.